HSBC HOLDINGS PLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$234,189
-86.8%
6,623
-86.0%
0.00%
-100.0%
Q2 2022$1,776,000
+633.9%
47,206
+615.6%
0.00%
Q1 2022$242,000
-35.6%
6,597
-30.1%
0.00%
Q2 2021$376,000
-42.0%
9,435
-34.5%
0.00%
-100.0%
Q1 2021$648,000
-33.6%
14,415
-16.8%
0.00%0.0%
Q4 2020$976,000
-52.7%
17,334
-59.9%
0.00%
-66.7%
Q3 2020$2,064,000
+181.2%
43,175
+247.0%
0.00%
+200.0%
Q2 2020$734,000
+36.9%
12,444
+10.0%
0.00%0.0%
Q1 2020$536,000
-82.2%
11,314
-77.1%
0.00%
-80.0%
Q4 2019$3,016,000
+112.1%
49,434
+108.3%
0.01%
+66.7%
Q3 2019$1,422,000
+90.9%
23,727
+104.9%
0.00%
+200.0%
Q2 2019$745,000
+10.4%
11,580
+39.3%
0.00%0.0%
Q1 2019$675,000
+74.4%
8,311
-49.9%
0.00%0.0%
Q2 2016$387,000
-46.5%
16,599
-7.0%
0.00%
-50.0%
Q1 2016$723,000
-41.4%
17,846
-10.4%
0.00%
-33.3%
Q4 2015$1,234,00019,9250.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders